Immunohistochemical study of hepatocyte paraffin 1 antibody, monoclonal antibody 31, and cytokeratin 7 in primary and secondary liver carcinomas

Author:

Mohamed Said Abu-Alkhair

Abstract

Background Primary hepatic malignant epithelial neoplasia includes several different types of tumors, among which includes cholangiocarcinoma (CC), the second most frequent cancer of the liver after hepatocellular carcinoma (HCC). However, the most common hepatic epithelial malignant neoplasms are metastatic adenocarcinomas (AC). Hepatocyte paraffin 1 antibody (Hep Par 1) is a monoclonal antibody that reacts with normal and neoplastic liver cell. Anti-epithelial cell adhesion molecule monoclonal antibody 31 (MOC-31) is an antibody directed against a cell surface glycoprotein. Cytokeratin 7 (CK7) is expressed in normal and neoplastic epithelia. Aim To study the usefulness of the immunohistochemistry of Hep Par 1, MOC-31, and CK7 in differentiating primary and secondary carcinomas in the liver. Materials and methods The present study included 45 specimens from cases of primary and metastatic liver tumors, including 15 primary HCCs in the liver, four intrahepatic CCs, and 26 metastatic ACs in the liver. They were studied to evaluate Hep Par 1, MOC-31, and CK7 expression. Results The sensitivity of Hep Par 1 for HCC in the study group was 73.3%, whereas its specificity was 100%. The sensitivity of MOC-31 for AC in the study group was 96.4%, whereas its specificity was 91%. The sensitivity of CK7 for CC in the study group was 100%, whereas its specificity was 54%. Conclusion Hep Par 1 has very sensitive and specific immunostaining for HCC, MOC-31 is a useful marker for AC with high sensitivity and specificity, and CK7 is highly sensitive for CC but its specificity is low. A combination of Hep Par 1 and MOC-31 is the most useful combination of two antibodies for the distinction between HCC and AC.

Publisher

Medknow

Reference24 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3